HEPATITIS C VIRUS (HCV)
Clinical trials for HEPATITIS C VIRUS (HCV) explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C VIRUS (HCV) trials appear
Sign up with your email to follow new studies for HEPATITIS C VIRUS (HCV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New program aims to cut HIV and overdose risks for people leaving jail
Prevention Recruiting nowThis study tests a program called MEPS that uses a mobile app, peer mentors, and incentives to help people recently released from jail access HIV prevention (like PrEP), STI testing, and substance use treatment. About 300 people across three California counties will take part. Th…
Matched conditions: HEPATITIS C VIRUS (HCV)
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated May 16, 2026 22:29 UTC
-
Real-World study probes hepatitis c drug safety in drug users
Knowledge-focused Recruiting nowThis study looks back at medical records of 2000 people with hepatitis C who took an 8-week treatment called Glecaprevir/Pibrentasvir. The goal is to see how safe and effective the treatment is for those also taking prescription or illegal drugs. Researchers will track side effec…
Matched conditions: HEPATITIS C VIRUS (HCV)
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated May 16, 2026 22:27 UTC
-
Prison needle exchange study aims to curb HIV and hepatitis c behind bars
Knowledge-focused Recruiting nowThis study aims to increase the use of needle and syringe programs in Canadian federal prisons to reduce the spread of HIV and hepatitis C among people who inject drugs. Researchers will work in nine prisons, including five women's prisons, to identify barriers and test strategie…
Matched conditions: HEPATITIS C VIRUS (HCV)
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC